<乌鸦传媒>FDA OKs Laser-Assisted IVC Filter Removal Another option for hard-to-remove filters Dec 21, 2021
<乌鸦传媒>ECG Monitoring for Post-TAVR Delayed Conduction Disturbances Put to the Test How long should monitoring last, and in whom? Dec 20, 2021
<乌鸦传媒>Bentracimab on Point as Fast-Acting Ticagrelor Reversal Agent "Immediate and sustained" benefit, interim REVERSE-IT analysis found Nov 17, 2021
<乌鸦传媒>PALACS: A Win for Posterior Left Pericardiotomy for Post-Op Afib Trial offers good news for patients getting coronary, aortic valve, and aortic surgeries Nov 14, 2021
<乌鸦传媒>Tricuspid Repair Boosts Mitral Valve Surgery Outcomes Randomized trial supports combined surgery for moderate regurgitation Nov 13, 2021
<乌鸦传媒>Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
<乌鸦传媒>DCBs for the Coronaries: Early Victories for New Drug Coatings Researchers eye next gen drug-coated balloons despite lack of FDA OK for use in PCI Nov 07, 2021
<乌鸦传媒>Gastrointestinal Damage Nearly Universal With Antiplatelet Use After PCI Noninvasive endoscopy in OPT-PEACE reveals surprises about GI effects of antiplatelets Nov 07, 2021
<乌鸦传媒>Longstanding Vascular Closure Technique Triumphs Over Collagen Plug Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
<乌鸦传媒>TAVR Chugging Along at 5 Years in SURTAVI Trial Plus, data suggest that it is probably cost-effective in low-risk patients Nov 06, 2021
<乌鸦传媒>TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
<乌鸦传媒>Surgery Keeps Edge Over Contemporary Stenting for Multivessel CAD Large noninferiority margin still not enough in FAME 3 trial Nov 04, 2021
<乌鸦传媒>Signs Point to Half-Dose DOAC Route After Watchman Procedure Search continues for best antithrombotic strategy after LAA closure Oct 13, 2021
<乌鸦传媒>Study: Kids Exposed to Harmful Plastics During Heart Surgery Are tubing and blood bags sources of trouble? Oct 09, 2021
<乌鸦传媒>Post-TAVR Pacemakers Not All Doom and Gloom A bit of reassurance from Swedish cohort study Oct 04, 2021
<乌鸦传媒>Radiation or Surgery in Early Lung Cancer: Does It Make a Difference? Ablative radiation still noninferior to VATS after longer follow-up Sep 24, 2021
<乌鸦传媒>Low Risk and Bicuspid Anatomy: A Passable Combination for TAVR Thus Far Clinical outcomes not worse compared with tricuspid TAVR Sep 21, 2021
<乌鸦传媒>Better Late Than Never for Revascularization in STEMI Favorable outcomes for latecomers presenting up to 2 days after symptom onset Sep 20, 2021
<乌鸦传媒>More Data in Support of Surgery for Malignant Pleural Mesothelioma Six-month improvement in overall survival with surgery plus chemotherapy versus chemo alone Sep 13, 2021
<乌鸦传媒>Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesothelioma Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
<乌鸦传媒>LAA Occluder Opens Doors to Patients Who Can't Tolerate Blood Thinners Even Briefly The Amulet IDE trial that led to Amplatzer Amulet's FDA approval Aug 30, 2021
<乌鸦传媒>Edoxaban: A Mixed Bag for TAVR Patients Needing Anticoagulation Weighing positive efficacy data against excess GI bleeds Aug 28, 2021
<乌鸦传媒>Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
<乌鸦传媒>Are Hemoglobin Cutoffs for Anemia Outdated? A growing call for WHO criteria to be tightened Aug 06, 2021
<乌鸦传媒>TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
<乌鸦传媒>Urine Tests Before Surgery Blasted as Mostly Unnecessary Abundance of caution is way overdone, researchers suggest Aug 02, 2021
<乌鸦传媒>Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery Observational study suggests excess readmissions with less invasive procedure Jul 23, 2021
<乌鸦传媒>Watchman FLX Stays on Track for Stroke Prevention Next-generation LAA occluder maintains good results at 2 years Jul 22, 2021
<乌鸦传媒>Does COAPT Change the Need to Try Foundational HF Drugs in Functional MR? Current GDMT titration approach under fire during TVT debate Jul 21, 2021
<乌鸦传媒>After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be Unlikely Are observational data on highly selected patients good enough? Jul 21, 2021
<乌鸦传媒>FDA Breaks New Ground With Transplant Drug Approval No prospective trial offered or required Jul 19, 2021
<乌鸦传媒>Scarring on an Otherwise Normal Heart: Reassuring Data Emerge Phenomenon tied to very low burden of major arrhythmic events Jul 14, 2021
<乌鸦传媒>Trouble Looms With Pacemakers After Aortic Valve Replacement Permanent pacemaker implantation of clinical significance in cohort study Jul 13, 2021
<乌鸦传媒>FDA Piles on New Warnings for Blood Volume Expanders Hydroxyethyl starch products shouldn't be used for low blood volume unless no other options exist Jul 09, 2021
<乌鸦传媒>Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
<乌鸦传媒>Regenerative Therapy Makes Headway in HF ... in the Right Patients Study of autologous skeletal cell-patch implantation in Japan Jul 02, 2021
<乌鸦传媒>Medtronic's LVAD Pulled From Market Due to Neurological, Mortality Risks Physicians must stop implanting the HeartWare system, says FDA Jun 03, 2021
<乌鸦传媒>Passing Early-Term Report Cards for New Mitral, Tricuspid Valve Interventions A glance at devices coming down the structural heart pipeline in the coming years May 24, 2021
<乌鸦传媒>Navitor Shuts Out Leaky TAVR, but Pacemaker Rates a Concern? 30-day data for a new version of the Portico valve May 20, 2021
<乌鸦传媒>Invasive Treatment for Stable CAD: Is There a Cardiac Mortality Benefit? Discussion continues after ISCHEMIA's letdown for stenting and surgery May 19, 2021
